Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M102668200 on July 19, 2001

J. Biol. Chem., Vol. 276, Issue 40, 36902-36908, October 5, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/40/36902    most recent
M102668200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meinl, E.
Right arrow Articles by Hivroz, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meinl, E.
Right arrow Articles by Hivroz, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Herpesvirus saimiri Replaces ZAP-70 for CD3- and CD2-mediated T Cell Activation*

Edgar MeinlDagger §, Tobias DerfussDagger , Rainer Pirzer||, Norbert Blank**, Doris Lengenfelder||, Antoine BlancherDagger Dagger , Françoise Le Deist§§, Bernhard Fleckenstein||, and Claire Hivroz¶¶

From the Dagger  Department of Neuroimmunology, Max-Planck-Institute of Neurobiology, D-82152 Martinsried, Germany, § Institute for Clinical Neuroimmunology, Ludwig-Maximilians-University, 81377 Munich, Germany, || Institute for Clinical and Molecular Virology, University Erlangen-Nürnberg, 91054 Erlangen, Germany, ** Department of Internal Medicine III and Institute for Clinical Immunology, University of Erlangen-Nürnberg, 91054 Erlangen, Germany, Dagger Dagger  Hôpital Purpan, 31059 Toulouse, France, §§ INSERM U429, Hôpital Necker, 75015 Paris, France and ¶¶ INSERM U520, Institut Curie, 75248 Paris, France

The protein tyrosine kinase ZAP-70 plays a pivotal role involved in signal transduction through the T cell receptor and CD2. Defects in ZAP-70 result in severe combined immunodeficiency. We report that Herpesvirus saimiri, which does not code for a ZAP-70 homologue, can replace this tyrosine kinase. H. saimiri is an oncogenic virus that transforms human T cells to stable growth based on mutual CD2-mediated activation. Although CD2-mediated proliferation of ZAP-70-deficient uninfected T cells was absent, we could establish H. saimiri-transformed T cell lines from two unrelated patients presenting with ZAP-70 deficiencies. In these cell lines, CD2 and CD3 activation were restored in terms of [Ca2+]i, MAPK activation, cytokine production, and proliferation. Activation-induced tyrosine phosphorylation of zeta  remained defective. The transformed cells expressed very high levels of the ZAP-70-related kinase Syk. This increased expression was not observed in the primary T cells from the patients and was not due to the transformation by the virus because transformed cell lines established from control T cells did not present this particularity. In conclusion, wild type H. saimiri can restore CD2- and CD3-mediated activation in signaling-deficient human T cells. It extends our understanding of interactions between the oncogenic H. saimiri and the infected host cells.


* This work was supported by the Deutsche Forschungsgemeinschaft (SFB 466 and SFB 571) and the Wilhelm Sander-Stiftung (97.081.1). The Institute of Clinical Neuroimmunology is supported by the Hermann and Lilly Schilling Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Neuroimmunology, Max-Planck-Institute of Neurobiology, D-82152 Martinsried, Germany. Tel.: 49-89-8578-3519; Fax: 49-89-8995-0163; E-mail: meinl@neuro.mpg.de.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
E. Heck, U. Friedrich, M. U. Gack, D. Lengenfelder, M. Schmidt, I. Muller-Fleckenstein, B. Fleckenstein, A. Ensser, and B. Biesinger
Growth transformation of human T cells by herpesvirus saimiri requires multiple tip-lck interaction motifs.
J. Virol., October 1, 2006; 80(20): 9934 - 9942.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. M. Sorokina, J. J. Merlo Jr., and A. Y. Tsygankov
Molecular Mechanisms of the Effect of Herpesvirus saimiri Protein StpC on the Signaling Pathway Leading to NF-{kappa}B Activation
J. Biol. Chem., April 2, 2004; 279(14): 13469 - 13477.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
P. S. Torres, D. A. Zapata, A. Pacheco-Castro, J. L. Rodriguez-Fernandez, C. Cabanas, and J. R. Regueiro
Contribution of CD3{gamma} to TCR regulation and signaling in human mature T lymphocytes
Int. Immunol., November 1, 2002; 14(11): 1357 - 1367.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement